MiRagen Therapeutics Inc. plans to raise up to $50 million in an at-the-market issuance of common stock, with Cowen and Co. LLC acting as the sales agent.
Discover more about S&P Global’s offerings
MiRagen to raise $50M via common stock issuance
Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy
MiRagen Therapeutics Inc. plans to raise up to $50 million in an at-the-market issuance of common stock, with Cowen and Co. LLC acting as the sales agent.